eCOA Resources
-
Improving Oncology Trial Experiences & Efficiencies Digital Solutions
4/11/2023
Uncover how a top-10 pharmaceutical company was able to overcome oncology clinical study obstacles with a digital software platform.
-
Why The Future Looks Bright For eCOA In Clinical Trials
5/16/2023
Unearth the ways electronic clinical outcome assessment technology is revolutionizing data collection, improving patient experiences, and enhancing trial outcomes.
-
Using Remote Image Capture eCOA For Hybrid Dermatology Trials
2/1/2022
From eRecruitment, pre-screening, eConsent, and image-based data capture, explore how a decentralized trial design helps streamline enrollment, increase patient retention, and ensure data quality.
-
From Complexity To Clarity: Automate eCOA Configuration With AI
9/9/2025
Clinical trials are more complex than ever, but building and launching global studies doesn’t have to be.
-
Building A Scalable Oncology Engine In A Dynamic Market
6/3/2026
Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.
-
Maximize Control And Transparency On The Path To Study Go-Live
10/10/2024
Simplify the historically complicated, black-box processes around eCOA solution deployment, content storage and visualization, and global go-live.
-
eCOA Best Practices For Crohn's And UC Trials
1/27/2025
Around 200 trials annually use tools like the Crohn’s Disease Activity Index (CDAI) and Modified Mayo Score (mMS) to measure clinical remission. Implementing these in eCOA systems requires careful planning.
-
A Review Of The Changing Trends And Use Of eCOA In Clinical Trials
11/17/2023
Delve into how electronic clinical outcome assessments are being transformed through new technologies, the maturation of digital organizations, and increased endorsement from regulatory bodies.
-
Simplifying ePRO Data Collection
10/4/2024
The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.
-
Letter From The CEO: A New Era Of Drug Development Is Here
9/3/2024
This letter from Medable CEO Michelle Longmire lays out why we created Studio, what it enables sponsors and CROs to do, and how it will help everyone bring more effective therapies to patients faster.